Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 November 2016 |
Main ID: |
NCT02463552 |
Date of registration:
|
29/05/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Naproxen on Tooth Sensitivity Caused by In-office Bleaching
|
Scientific title:
|
Rior Use of Naproxen on Tooth Sensitivity Reduction After In-office Bleaching: Randomized Clinical Trial |
Date of first enrolment:
|
May 2015 |
Target sample size:
|
50 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02463552 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Brazil
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- At least 18 years old patients of both genders presenting good general/oral health;
- All maxillary anterior teeth presenting shade equal or darker than 2M2 at Vita
bleachguide guide (Vita-Zahnfabrik, Germany);
- Signed the form accepting to participate of this study.
Exclusion Criteria:
- Presence of caries lesions, restorations and/or endodontic treatment at any maxillary
anterior teeth.
- Undergone tooth-whitening procedures;
- Pregnant/lactating;
- Presence of periodontal diseases;
- Presence of severe tooth discoloration by tetracycline stains or fluorosis;
- Any kind of medicine, bruxism habits or any other pathology that can cause
sensitivity (such as recession, dentin exposure);
- Continuous use of drugs with anti-inflammatory actions;
- Presence of tooth hypersensitivity at baseline measurement;
- Any known adverse effects caused by Naproxen;
- Non-attendance to any session of evaluation or bleaching.
Age minimum:
18 Years
Age maximum:
35 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Toothache
|
Tooth Bleaching
|
Intervention(s)
|
Drug: Naproxen
|
Primary Outcome(s)
|
Risk to Tooth sensitivity - during procedure
[Time Frame: During the bleaching procedure]
|
Secondary Outcome(s)
|
Level of tooth sensitivity - after procedure
[Time Frame: 24 hours after bleaching prcedure]
|
Risk of tooth sensitivity - after procedure
[Time Frame: 24 hours after bleaching prcedure]
|
Level of tooth sensitivity - during procedure
[Time Frame: During the bleaching procedure]
|
Secondary ID(s)
|
UFSergipe
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|